Noninvasive molecular test for colorectal polyps before colonoscopy
Official title: Metatranscriptomic Markers As A Predictor of Colonic Neoplasia at the Time of Colonoscopy
Run by Viome · NCT07786818 · Data updated 2026-11-12
This study tests whether saliva and stool markers can predict the presence of colorectal polyps in adults undergoing colonoscopy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Viome Industry-sponsored |
| Locations | 1 site (Bothell, Washington) |
| Status | Recruiting |
| Started | December 20, 2025 |
| Main results expected | January 30, 2027 |
| Study ends | January 30, 2027 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT07786818 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older undergoing colonoscopy who can provide stool and saliva samples and have no personal history of colorectal cancer or stoma.
✕Probably not a fit
Participants with colorectal polyps may not benefit directly if the test does not achieve sufficient accuracy in predicting polyps.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects saliva and stool samples from about 1,000 adults scheduled for colonoscopy to identify molecular features associated with colonoscopy-detected polyps. Researchers will build a predictive model using the initial data and test it on an independent validation dataset to see how well it identifies individuals with polyps. The work is a collaboration between Viome Life Sciences and Scripps Research Institute, with no interventions applied to participants beyond standard care and sample collection. Eligibility includes adults 18+ undergoing colonoscopy with bowel prep who can provide stool and saliva; those with a stoma or a personal history of colorectal cancer are excluded.
Why it matters
Potential benefit: If successful, the test could offer a noninvasive way to flag people at higher risk for colorectal polyps.
How similar studies have gone: Prior research in multi-omics and metatranscriptomic approaches has shown promise for noninvasive detection of colorectal neoplasia, but independent validation is needed for this specific marker approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, aged 18 years or older * Undergoing colonoscopy with bowel preparation * Able to provide stool and saliva samples prior to colonoscopy * No stoma present * No known personal history of colorectal cancer Exclusion Criteria: * Individuals under 18 years of age * Patients with a stoma * Personal history of colorectal cancer
Where it's running
-
Viome Life Sciences
Bothell, Washington, United States Recruiting
Study contacts
- Study coordinator: Momchilo Vuyisich, PhD
- Email: studies@viome.com
- Phone: 855-958-4663
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Post-polypectomy scar: comparing four imaging methods to find residual tissue
Doctors will test four imaging methods to see which best detects leftover or recurrent tissue at colonoscopy scars after large polyps were removed.
-
SUBMO for Submucosal Injection in Endoscopic Resection of Colorectal Polyps
This trial tests whether SUBMO®, a hyaluronic acid-based gel with blue dye, can safely and effectively replace saline for submucosal injection during endoscopic removal of colorectal polyps larger than 10 mm.
-
Digital training to improve optical diagnosis of colorectal polyps
This project will test whether a digital training app helps doctors more accurately predict polyp tissue type during colonoscopy for adults who have polyps.
-
Using SCALE-EYE to measure colorectal polyp size accurately and reduce procedure waste
This trial tests whether SCALE-EYE can accurately measure polyp size during screening or surveillance colonoscopy in people aged 55–80 and whether its use can cut down on follow-up procedures and waste.
-
3D imaging during colonoscopy to find high-risk adenomas
This trial tests whether a 3D imaging device used during colonoscopy helps identify patients with high-risk adenomas better than standard 2D imaging.
-
Using AI to predict polyp pathology during colonoscopy
This study is testing whether a new AI tool can help doctors better identify and classify polyps during colonoscopy to improve patient care and reduce unnecessary procedures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.